Literature DB >> 24186126

Prerequisite for His(4) in deltorphin A for highδ opioid receptor selectivity.

S Salvadori1, R Guerrini, V Forlani, S D Bryant, M Attila, L H Lazarus.   

Abstract

Analysis of deltorphin A position 4 analogues included: backbone constrained N (α) MeHis, spinacine (Spi), N (α) MePhe and the tetrahydroisoquinoline-3-carboxylic acid (Tic); spatially confined side-chain (Phg); and imidazole alkylation ofL- andD-His(4) enantiomers. Highδ selectivity was lost with the following replacements: N (α) MeHis(4), N (α) MePhe(4) and Phg(4) reducedδ binding and the constrained residues also increasedµ binding; ring closure between the side-chain and amino group to yield Spi(4) or Tic(4) increasedµ affinity. Imidazole methylation of His(4) marginally affected opioid binding and doubledδ selectivity; alkylatedD-His(4)-derivatives generally maintainedδ selectivity in spite of decreasedδ affinities. Thus, His(4) imidazole preservesδ selectivity by facilitating highδ binding and by repulsion at theµ receptor. Several low energy conformers of deltorphin A indicated that the His(4) imidazole preferred a spatial orientation parallel to the phenolic side-chain of Tyr(1) suggestive that this conformation might contribute to highδ affinity and selectivity.

Entities:  

Year:  1994        PMID: 24186126     DOI: 10.1007/BF00807704

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  40 in total

1.  Cloning of a delta opioid receptor by functional expression.

Authors:  C J Evans; D E Keith; H Morrison; K Magendzo; R H Edwards
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

Review 2.  The opioid peptides of the amphibian skin.

Authors:  V Erspamer
Journal:  Int J Dev Neurosci       Date:  1992       Impact factor: 2.457

3.  Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes.

Authors:  K Fukuda; S Kato; K Mori; M Nishi; H Takeshima
Journal:  FEBS Lett       Date:  1993-08-02       Impact factor: 4.124

4.  Amino acid composition and sequence of dermorphin, a novel opiate-like peptide from the skin of Phyllomedusa sauvagei.

Authors:  P C Montecucchi; R de Castiglione; S Piani; L Gozzini; V Erspamer
Journal:  Int J Pept Protein Res       Date:  1981-03

5.  Dimeric dermorphin analogues as mu-receptor probes on rat brain membranes. Correlation between central mu-receptor potency and suppression of gastric acid secretion.

Authors:  L H Lazarus; A Guglietta; W E Wilson; B J Irons; R de Castiglione
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

6.  cDNAs encoding [D-Ala2]deltorphin precursors from skin of Phyllomedusa bicolor also contain genetic information for three dermorphin-related opioid peptides.

Authors:  K Richter; R Egger; L Negri; R Corsi; C Severini; G Kreil
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  [D-Ala2]deltorphin II analogs with high affinity and selectivity for delta-opioid receptor.

Authors:  Y Sasaki; A Ambo; K Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1991-10-31       Impact factor: 3.575

8.  The aspartic acid in deltorphin I and dermenkephalin promotes targeting to delta-opioid receptor independently of receptor binding.

Authors:  S Sagan; S Charpentier; A Delfour; M Amiche; P Nicolas
Journal:  Biochem Biophys Res Commun       Date:  1992-09-30       Impact factor: 3.575

9.  A topochemical approach to explain morphiceptin bioactivity.

Authors:  T Yamazaki; S Ro; M Goodman; N N Chung; P W Schiller
Journal:  J Med Chem       Date:  1993-03-19       Impact factor: 7.446

10.  Molecular mechanics studies of dermorphin.

Authors:  N Pattabiraman; K R Sorensen; R Langridge; R S Bhatnagar; V Renugopalakrishnan; R S Rapaka
Journal:  Biochem Biophys Res Commun       Date:  1986-10-15       Impact factor: 3.575

View more
  1 in total

Review 1.  Conformationally constrained histidines in the design of peptidomimetics: strategies for the χ-space control.

Authors:  Azzurra Stefanucci; Francesco Pinnen; Federica Feliciani; Ivana Cacciatore; Gino Lucente; Adriano Mollica
Journal:  Int J Mol Sci       Date:  2011-05-03       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.